Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0739
Full Text
Open PDFAbstract
Available in full text
Date
December 26, 2018
Authors
Publisher
American Association for Cancer Research (AACR)